Experimental Model to Evaluate Resolution of Pneumonia

J Vis Exp. 2023 Feb 17:(192). doi: 10.3791/63925.

Abstract

Acute respiratory distress syndrome (ARDS) causes acute lung injury, characterized by rapid alveolar damage and severe hypoxemia. This, in turn, leads to high morbidity and mortality. Currently, there are no pre-clinical models that recapitulate the complexity of human ARDS. However, infectious models of pneumonia (PNA) can replicate the main pathophysiological features of ARDS. Here, we describe a model of PNA induced by the intratracheal instillation of live Streptococcus pneumoniae and Klebsiella pneumoniae in C57BL6 mice. In order to evaluate and characterize the model, after inducing injury, we carried out serial measurements of body weight and bronchoalveolar lavage (BAL) for measuring markers of lung injury. Additionally, we harvested lungs for cell count and differentials, BAL protein quantification, cytospin, bacterial colony-forming unit counts, and histology. Lastly, high dimensional flow cytometry was performed. We propose this model as a tool to understand the immune landscape during the early and late resolution phases of lung injury.

Publication types

  • Video-Audio Media
  • Research Support, N.I.H., Extramural

MeSH terms

  • Acute Lung Injury*
  • Animals
  • Dimercaprol
  • Humans
  • Mice
  • Mice, Inbred C57BL
  • Models, Theoretical
  • Pneumonia*
  • Streptococcus pneumoniae

Substances

  • Dimercaprol